chevron_leftBack
As of 16 June 2026, Lionco Pharmaceutical Group Co.,Ltd. has a market cap of $467.03M USD, ranking #15599 globally and #4898 in China.
It ranks #1391 in the Healthcare sector, and #79 in the Drug Manufacturers - Specialty & Generic industry.
Key Stats
Market Cap
$467.03MUSD
3.16B CNY
Enterprise Value
$485.18MUSD
3.28B CNY
Revenue (TTM)
$47.65MUSD
322.48M CNY
EBITDA (TTM)
-$9.19MUSD
-62.19M CNY
Net Income (TTM)
-$28.55MUSD
-193.24M CNY
EBITDA Margin
-19%
Profit Margin
-60%
PS Ratio
9.8
PB Ratio
5.1
Company Profile
Country (HQ)
Sector
Healthcare
CEO
Ling Ping Tao
open_in_new
Employees
436
Founded
2003
Website
lingkang.com.cn
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -1.5% | 7% | 1.1% | -0.9% | -17% | 6.3% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
603669
灵康药业集团股份有限公司 Class A
ISIN: CNE1000022R8
Shares Out.:
Shares Outstanding:
694.628M1
Shares Float:
321.127M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
4.48 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Lionco Pharmaceutical Group Co.,Ltd.
Lionco Pharmaceutical Group Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical products and medical services in China. It offers chemical and prescription drugs for nutrition, antimicrobial, antiviral, digestive, cardiovascular, cerebrovascular, detoxification, anti-tumor, and other applications. The company was founded in 2003 and is based in Shannan, China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SHE: 002001
|
$15.86B
3K%
107.34B CNY
|
16.0
|
|
SHE: 002653
|
$9.1B
2K%
61.6B CNY
|
80.6
|
|
SHE: 000423
|
$5.22B
1K%
35.33B CNY
|
20.0
|
|
SHE: 002603
|
$4.21B
801%
28.47B CNY
|
20.8
|
|
SHE: 000623
|
$3.27B
600%
22.12B CNY
|
8.1
|
|
|
$2.74B
487%
18.55B CNY
|
11.5
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TLV: TEVA
|
$37.29B
8K%
108.92B ILS
|
24.2
|
|
NASDAQ: RVMD
|
$29.56B
6K%
|
-
|
|
NSE: CIPLA
|
$11.17B
2K%
1.06T INR
|
23.4
|
|
NSE: LUPIN
|
$11.05B
2K%
1.05T INR
|
22.7
|
|
EPA: ABVX
|
$8.75B
2K%
7.57B EUR
|
-
|
|
NSE: AUROPHARMA
|
$8.47B
2K%
807.02B INR
|
23.1
|
chevron_leftBack